Important for
Prelims: Science & Technology
Mains: General Studies III
What is in the News?
- The national public health agency of the United States Centers for Disease Control and Prevention has expressed concern that a drug-resistant bacteria strain allegedly linked to eye- drops imported from India could gain a foothold in U.S. health care settings.
Info Regarding this Strain
- It is “extensively” antibiotic-resistant Pseudomonas aeruginosa bacteria found in multiple open containers of eye drops.
- Pseudomonas aeruginosa can cause infections in the blood, lungs (pneumonia), or other parts of the body after surgery.
India’s Role
- The eye drops were manufactured by Chennai-based Global Pharma Healthcare and distributed in the U.S. market by EzriCare and Delsam Pharma.
- Previously, WHO had issued two medical product alerts on cough syrups manufactured in India which were exported to Gambia and Uzbekistan.
India’s Role : Requirements for Pharma Exporters
- Manufacturing of drugs for export needs licensing from the concerned State Licensing Authority (SLA) under the provisions of the Drugs and Cosmetics Act,1940
- All manufacturers were required to meet the requirements of the importing country.
Practice Questions for Prelims
Mains Practice Question
Leave a Reply
You must be logged in to post a comment.